The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies
Open accessAbstract
Nanoparticles have received enormous attention as a promising tool to enhance target-specific drug delivery and diagnosis. Various in vitro and in vivo techniques are used to characterize a new system and predict its clinical efficacy. These techniques enable efficient comparison across nanoparticles and facilitate a product optimization process. On the other hand, we recognize their limitations as a prediction tool, due to inadequate applications and overly simplified test conditions. We provide a critical review of in vitro and in vivo techniques currently used for evaluation of nanoparticles and introduce emerging techniques and models that may be used complementarily.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
Laurell, C.-B. (1966) · Analytical Biochemistry · doi:10.1016/0003-2697(66)90246-6 · Cited by 4,401
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Kalyanasundaram, K., & Thomas, J. K. (1977) · Journal of the American Chemical Society · doi:10.1021/ja00449a004 · Cited by 3,464
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Research works printed but not linked: 33
- Saveyn H., 2010, J. Colloid Interface Sci., 352, 593, 10.1016/j.jcis.2010.09.006 · doi:10.1016/j.jcis.2010.09.006
- Finder C., 2004, Part. Part. Syst. Charact., 21, 372, 10.1002/ppsc.200400948 · doi:10.1002/ppsc.200400948
- Bowen P., 2002, J. Dispersion Sci. Technol., 23, 631, 10.1081/DIS-120015368 · doi:10.1081/dis-120015368
- Accardo A., 2004, J. Am. Chem. Soc., 126, 3097, 10.1021/ja039195b · doi:10.1021/ja039195b
- Needham D., 2000, Cancer Res., 60, 1197
- Pişkin E., 2004, Int. J. Pharm., 277, 105, 10.1016/j.ijpharm.2003.06.003 · doi:10.1016/j.ijpharm.2003.06.003
- Isaacs S. R., 2005, Chem. Mater., 18, 107, 10.1021/cm0518980 · doi:10.1021/cm0518980
- Matsumura Y., 1986, Cancer Res., 46, 6387
- Zhang W., 2008, J. Microencapsulation, 25, 203, 10.1080/02652040701852181 · doi:10.1080/02652040701852181
- Boackle R., 1983, Mol. Immunol., 20, 1157, 10.1016/0161-5890(83)90139-6 · doi:10.1016/0161-5890(83)90139-6
- Suzuki Y., 2003, Carbohydr. Polym., 54, 465, 10.1016/j.carbpol.2003.07.002 · doi:10.1016/j.carbpol.2003.07.002
- Ekkapongpisit M., 2012, Int. J. Nanomed., 7, 4147
- Anirudhan T. S., 2011, New J. Chem., 35, 2869, 10.1039/c1nj20672a · doi:10.1039/c1nj20672a
- Han S. E., 2009, J. Drug Targeting, 17, 123, 10.1080/10611860802472461 · doi:10.1080/10611860802472461
- Lei T. J., 2011, Nanomedicine, 7, 324, 10.1016/j.nano.2010.11.004 · doi:10.1016/j.nano.2010.11.004
- Mitra M., 2012, Mol. Vision, 18, 1361
- Huang S. K., 1992, Cancer Res., 52, 6774
- Vaage J., 1994, Cancer, 73, 1478, 10.1002/1097-0142(19940301)73:5<1478::AID-CNCR2820730526>3.0.CO;2-1 · doi:10.1002/1097-0142(19940301)73:5<1478::aid-cncr2820730526>3.0.co;2-1
- Vaage J., 1993, Cancer, 72, 3671, 10.1002/1097-0142(19931215)72:12<3671::AID-CNCR2820721219>3.0.CO;2-U · doi:10.1002/1097-0142(19931215)72:12<3671::aid-cncr2820721219>3.0.co;2-u
- Van Oosterom A. T., 1986, Eur. J. Cancer Clin. Oncol., 22, 601, 10.1016/0277-5379(86)90050-7 · doi:10.1016/0277-5379(86)90050-7
- Lawton P. A., 1993, Clin. Oncol. (R. Coll. Radiol.), 5, 80, 10.1016/S0936-6555(05)80851-9 · doi:10.1016/s0936-6555(05)80851-9
- Cowan J. D., 1985, Invest. New Drugs, 3, 149, 10.1007/BF00174162 · doi:10.1007/bf00174162
- Pfeiffer P., 1992, Acta Oncol., 31, 219, 10.3109/02841869209088906 · doi:10.3109/02841869209088906
- Li C., 1998, Cancer Res., 58, 2404
- McDonald D. M., 2002, Cancer Res., 62, 5381
- Kuo T. H., 1993, Anticancer Res., 13, 627
- Hoffman R. M., 2005, Methods Mol. Med., 111, 297
- Chishima T., 1997, Cancer Res., 57, 2042
- El Hilali N., 2002, Lab. Invest., 82, 1563, 10.1097/01.LAB.0000036877.36379.1F · doi:10.1097/01.lab.0000036877.36379.1f
- Oh P., 2009, FASEB J., 23, 438.11
- Frost G. I., 2005, Microvasc. Res., 69, 1, 10.1016/j.mvr.2004.10.001 · doi:10.1016/j.mvr.2004.10.001
- Dibirdik I., 2010, J. Nanomed. Nanotechnol., 1, 001, 10.4172/2157-7439.1000101 · doi:10.4172/2157-7439.1000101
- Uckun F. M., 2004, Arzneim. Forsch., 54, 715
Cited by
Engineered nanoparticles interacting with cells: size matters
Shang, L., Nienhaus, K., & Nienhaus, G. U. (2014) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-12-5 · Cited by 1,316
A review on the classification, characterisation, synthesis of nanoparticles and their application
Anu Mary Ealia, S., & Saravanakumar, M. P. (2017) · IOP Conference Series: Materials Science and Engineering · doi:10.1088/1757-899x/263/3/032019 · Cited by 1,050
Khan, Y., Sadia, H., Ali Shah, S. Z., Khan, M. N., Shah, A. A., Ullah, N., Ullah, M. F., Bibi, H., Bafakeeh, O. T., Khedher, N. B., et al. (2022) · Catalysts · doi:10.3390/catal12111386 · Cited by 664
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Nanoparticle Characterization: What to Measure?
Modena, M. M., Rühle, B., Burg, T. P., & Wuttke, S. (2019) · Advanced Materials · doi:10.1002/adma.201901556 · Cited by 498
Metadata
- Authors
- Cho, E. J., Holback, H., Liu, K. C., Abouelmagd, S. A., Park, J., & Yeo, Y.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-03-21
- Volume
- 10
- Issue
- 6
- Pages
- 2093-2110
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1990424094
- Cited by
- 382
- References
- 181
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies. https://app.cochat.ai/papers/10.1021/mp300697h
- The paper
- Cho, E. J., Holback, H., Liu, K. C., Abouelmagd, S. A., Park, J., & Yeo, Y. (2013). Nanoparticle Characterization: State of the Art, Challenges, and Emerging Technologies. Molecular Pharmaceutics. https://doi.org/10.1021/mp300697h
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.